Dopamine Uptake Inhibitors
Research News and Information

Saturday, November 21, 2009

A neurocomputational model for cocaine addiction.

29 Sep 2009 Based on the dopamine hypotheses of cocaine addiction and the assumption of decrement of brain reward system sensitivity after long-term drug exposure, we propose a computational model for cocaine addiction. Utilizing average reward temporal ... Read more...

Varenicline and suicidal behaviour: a cohort study based on data from the General Practice Research Database.

29 Sep 2009 OBJECTIVE: To determine whether varenicline, a recently licensed smoking cessation product, is associated with an increased risk of suicide and suicidal behaviour compared with alternative treatments bupropion and nicotine replacement therapy. ... Read more...

In vitro autoradiography and in vivo evaluation in cynomolgus monkey of [18F]FE-PE2I, a new dopamine transporter PET radioligand.

29 Sep 2009 This study evaluated the in vitro and in vivo characteristics of a new dopamine transporter (DAT) radioligand, [(18)F]fluoroethyl(FE)PE2I, by autoradiography from postmortem human brain and by positron emission tomography (PET) in three cynomolgus ... Read more...

Latest indexed articles for 'Dopamine Uptake Inhibitors'

These are the very latest articles for this heading:

• A neurocomputational model for cocaine addiction. 29 Sep 2009
• Varenicline and suicidal behaviour: a cohort study based on data from the General Practice Research Database. 29 Sep 2009
• Smoking cessation: how to advise the patient. 29 Sep 2009
• In vitro autoradiography and in vivo evaluation in cynomolgus monkey of [18F]FE-PE2I, a new dopamine transporter PET radioligand. 29 Sep 2009
• Regulation of dynamin 2 and G protein-coupled receptor kinase 2 in rat nucleus accumbens during acute and repeated cocaine administration. 29 Sep 2009
• c-Fos expression associated with reinstatement of cocaine-seeking behavior by response-contingent conditioned cues. 29 Sep 2009
• [Neuroenhancement: doping for the brain] 27 Sep 2009
• Struck from behind: maintaining quality of life with chronic low back pain. 30 Aug 2009
• Dopaminergic response to graded dopamine concentration elicited by four amphetamine doses. 30 Aug 2009
• Attenuated behavioural responses to acute and chronic cocaine in GASP-1-deficient mice. 25 Aug 2009
• Treating tobacco dependence in a medical setting. 23 Aug 2009
• In vivo evidence that constitutive activity of serotonin2C receptors in the medial prefrontal cortex participates in the control of dopamine release in the rat nucleus accumbens: differential effects of inverse agonist versus antagonist. 20 Aug 2009
• [Preventing weight gain in smoking cessation: there is no miracle solution] 3 Aug 2009
• A smoking ban in public places increases the efficacy of bupropion and counseling on cessation outcomes at 1 year. 2 Aug 2009
• Yoked delivery of cocaine is aversive and protects against the motivation for drug in rats. 30 Jul 2009
• A phase 1 trial of pharmacologic interactions between transdermal selegiline and a 4-hour cocaine infusion. 30 Jul 2009
• Naltrexone for the treatment of obesity: review and update. 30 Jul 2009
• Inactivating the activated: identifying functions of specific neural networks. 30 Jul 2009
• Plasticity of L-type Ca2+ channels after cocaine withdrawal. 30 Jul 2009
• Dopaminergic activity in depressed smokers: a positron emission tomography study. 30 Jul 2009

See a longer list of these articles.

Technical information about 'Dopamine Uptake Inhibitors'

Definition: Drugs that block the transport of DOPAMINE into axon terminals or into storage vesicles within terminals. Most of the ADRENERGIC UPTAKE INHIBITORS also inhibit dopamine uptake.

Registry Number: 0

Descriptor UI: D018765

Alternative terms: Dopamine Uptake Inhibitors; Reuptake Inhibitors, Dopamine; Inhibitors, Dopamine Uptake; Uptake Inhibitors, Dopamine; Inhibitors, Dopamine Reuptake; Dopamine Reuptake Inhibitors;

Allowable Qualifiers: history; immunology; isolation & purification; metabolism; pharmacokinetics; pharmacology; poisoning; radiation effects; standards; supply & distribution; therapeutic use; toxicity; urine; chemistry; contraindications; agonists; administration & dosage; adverse effects; analysis; antagonists & inhibitors; blood; cerebrospinal fluid; chemical synthesis; classification; diagnostic use; economics;

Tree Number: D27.505.519.625.150.800; D27.505.519.625.600.220; D27.505.696.577.150.800; D27.505.696.577.600.220;

History Note: 95

Technical Notes: GEN or unspecified; prefer specifics; DF: DOPAMINE UPTAKE INHIB